SCHEMBL20041269

SCHEMBL20041269

O=C(c1ccc([N+](=O)[O-])cc1)N1CCCC(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)C1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 14/20 0.69
▸ JUN P05412 10/20 0.69
▸ MAPK8 P45983 10/20 0.69
▸ MAPK9 P45984 10/20 0.69
▸ MAPK10 P53779 7/20 0.69
▸ CCNK O75909 10/20 0.67
▸ CDK12 Q9NYV4 10/20 0.67
▸ CDK9 P50750 9/20 0.67
▸ CDK7 P50613 9/20 0.67
▸ CCNH P51946 9/20 0.67
▸ CCNT1 O60563 8/20 0.67
▸ CDK13 Q14004 7/20 0.67
▸ MNAT1 P51948 7/20 0.67
▸ CCNA2 P20248 5/20 0.67
▸ CDK3 Q00526 1/20 0.67
▸ CCNE1 P24864 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21234360 1.00 CDK2 (0.69) CDK2JUNMAPK8MAPK9MAPK10
SCHEMBL20041398 0.89 CDK2 (0.73) CDK2JUNMAPK8MAPK9MAPK10
SCHEMBL21561673 0.89 CDK2 (0.73) CDK2JUNMAPK8MAPK9MAPK10
SCHEMBL18313056 0.89 CDK2 (0.75) CDK2JUNMAPK8MAPK9MAPK10
SCHEMBL16654839 0.85 CDK2 (0.73) CDK2JUNMAPK8MAPK9MAPK10
SCHEMBL16654836 0.85 CDK2 (0.73) CDK2JUNMAPK8MAPK9MAPK10
SCHEMBL16655011 0.85 CDK2 (0.73) CDK2JUNMAPK8MAPK9MAPK10
SCHEMBL21561657 0.84 CCNK (0.83) CDK2JUNMAPK8MAPK9MAPK10
SCHEMBL21561669 0.83 CDK2 (0.74) CDK2JUNMAPK8MAPK9MAPK10
SCHEMBL21561671 0.83 CDK7 (0.76) CDK2JUNMAPK8MAPK9MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057955-B1 HETEROAROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF PROLFERATIVE DISEASES SYROS PHARMACEUTICALS INC (US) 2018-04-11 — — EP disclosed
Send feedback